National Life Insurance Co. (XNEP:NLICL) Research & Development: NPR0 Mil (TTM As of Apr. 2026)


XNEP:NLICL National Life Insurance Co. Ltd XNEP:NLICL
98 GF Score
Price NPR572.00
GF Value NPR626.72
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is National Life Insurance Co. Research & Development?

National Life Insurance Co. XNEP:NLICL -0.17% 98 Research & Development is NPR0 Mil as of Apr. 2026. GuruFocus rates XNEP:NLICL with a GF Score™ of 98/100 and a GF Value™ of NPR626.72 (Fairly Valued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. National Life Insurance Co.'s Research & Development for the three months ended in Apr. 2026 was NPR0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 was NPR0 Mil.

National Life Insurance Co.  (XNEP:NLICL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

National Life Insurance Co. Research & Development Related Terms

National Life Insurance Co. Research & Development Historical Data

* Premium members only.

The historical data trend for National Life Insurance Co.'s Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

National Life Insurance Co. Research & Development Chart

National Life Insurance Co. Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

National Life Insurance Co. Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XNEP:NLICL
98GF Score
National Life Insurance Co. Ltd XNEP:NLICL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

National Life Insurance Co. Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NPR0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NPR0 Mil mean?
National Life Insurance Co. (XNEP:NLICL) has a Research & Development of NPR0 Mil as of Apr. 2026. Research and development expense is the total cost for research and development activities. View historical data on National Life Insurance Co. and its competitors.
Is National Life Insurance Co.'s Research & Development too high?
National Life Insurance Co.'s current Research & Development is NPR0 Mil. Overall, National Life Insurance Co. has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does National Life Insurance Co.'s Research & Development compare to AFL and MET?
National Life Insurance Co.'s Research & Development of NPR0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on National Life Insurance Co. and its competitors. National Life Insurance Co.'s current Research & Development is NPR0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Life Insurance Co. stock overvalued right now?
Based on GuruFocus' analysis, National Life Insurance Co. (XNEP:NLICL) is currently considered Fairly Valued. The stock's GF Value™ is NPR626.72, compared to a current price of NPR572.00 — trading 8.7% below its estimated fair value. The current Research & Development is NPR0 Mil. National Life Insurance Co.'s overall GF Score™ is 98/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For National Life Insurance Co. (XNEP:NLICL), the current Research & Development is NPR0 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is National Life Insurance Co. (XNEP:NLICL) Overvalued in 2026?

Based on GuruFocus' analysis, National Life Insurance Co. stock appears to be undervalued. The current stock price of NPR572.00 is trading 8.7% below its estimated GF Value™ of NPR626.72. GuruFocus considers National Life Insurance Co. to be Fairly Valued.

Key valuation signals for XNEP:NLICL:

  • Research & Development: NPR0 Mil
  • GF Value™: NPR626.72 vs. price of NPR572.00 (8.7% below fair value)
  • GF Score™: 98/100 with 5 warning signs

No single metric tells the full story. See the XNEP:NLICL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

National Life Insurance Co. Business Description

Address Ward No.2, Lazimpat, P.O. Box: 4332, Kathmandu Mahanagarpalika, Kathmandu, NPL, 1215
National Life Insurance Co. Ltd is engaged in the life insurance business, providing various life insurance products including participating and non-participating products through its province offices, branches, sub-branches, and network of agents. The company's offerings include individual plans, which consist of Endowment Assurance Plan, Childrens Plans, Money Back Plans, Whole Life Plans, Terms Assurance Plans, Retirement Plan and Single Premium Plan. The operating segments of the company include Endowment, Anticipated Endowment, Endowment Cum Whole Life, Foreign Employment Term, and Special Term. The company's main source of revenue is Premium Income, with the majority generated from endowment plans.
98GF Score

Get the complete analysis for XNEP:NLICL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NPR572.00
Price
NPR626.72
GF Value